Back to Journals » ImmunoTargets and Therapy » Volume 9 » default

ImmunoTargets and Therapy


Archive: Volume 9, 2020

Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications

Lillo AM, Velappan N, Kelliher JM, Watts AJ, Merriman SP, Vuyisich G, Lilley LM, Coombs KE, Mastren T, Teshima M, Stein BW, Wagner GL, Iyer S, Bradbury ARM, Harris JF, Dichosa AE, Kozimor SA

ImmunoTargets and Therapy 2020, 9:299-316

Published Date: 27 November 2020

Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma

Sepe P, Mennitto A, Corti F, Procopio G

ImmunoTargets and Therapy 2020, 9:273-288

Published Date: 13 November 2020

Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR

ImmunoTargets and Therapy 2020, 9:255-272

Published Date: 10 November 2020

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

Tanaka Y, Hoshino-Negishi K, Kuboi Y, Tago F, Yasuda N, Imai T

ImmunoTargets and Therapy 2020, 9:241-253

Published Date: 4 November 2020

GM-CSF: A Promising Target in Inflammation and Autoimmunity

Lee KMC, Achuthan AA, Hamilton JA

ImmunoTargets and Therapy 2020, 9:225-240

Published Date: 29 October 2020

Immunotherapeutic and Targeted Approaches in Multiple Myeloma

Nadeem O, Tai YT, Anderson KC

ImmunoTargets and Therapy 2020, 9:201-215

Published Date: 14 October 2020

Therapeutic Vaccines for HPV-Associated Malignancies

Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C

ImmunoTargets and Therapy 2020, 9:167-200

Published Date: 7 October 2020

Targeting IL-4 for the Treatment of Atopic Dermatitis

Chiricozzi A, Maurelli M, Peris K, Girolomoni G

ImmunoTargets and Therapy 2020, 9:151-156

Published Date: 29 September 2020

Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine

Andualem H, Kiros M, Getu S, Hailemichael W

ImmunoTargets and Therapy 2020, 9:143-149

Published Date: 29 September 2020

Factors Associated with Adherence to Immunosuppressive Therapy and Barriers in Asian Kidney Transplant Recipients [Corrigendum]

Ganjali R, Ghorban Sabbagh M, Nazemiyan F, Mamdouhi F, Badiee Aval S, Taherzadeh Z, Heshmati Nabavi F, Golmakani R, Tohidinezhad F, Eslami S

ImmunoTargets and Therapy 2020, 9:141-142

Published Date: 14 September 2020

Cannabidiol as a Novel Therapeutic for Immune Modulation

Peyravian N, Deo S, Daunert S, Jimenez JJ

ImmunoTargets and Therapy 2020, 9:131-140

Published Date: 18 August 2020

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model

Papaevangelou E, Smolarek D, Smith RA, Dasgupta P, Galustian C

ImmunoTargets and Therapy 2020, 9:115-130

Published Date: 27 July 2020

Assessing Immune Response to SARS-CoV-2 Infection

Shurin MR, Morris A, Wells A, Wheeler SE

ImmunoTargets and Therapy 2020, 9:111-114

Published Date: 11 June 2020

Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?

Lorenzo-Vizcaya A, Fasano S, Isenberg DA

ImmunoTargets and Therapy 2020, 9:105-110

Published Date: 2 June 2020

Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer

Tokhanbigli S, Asadirad A, Baghaei K, Piccin A, Yarian F, Parsamanesh G, Hashemi SM, Asadzadeh Aghdaei H, Zali MR

ImmunoTargets and Therapy 2020, 9:95-104

Published Date: 22 May 2020

Idiopathic CD4 Lymphocytopenia: Current Insights

Vijayakumar S, Viswanathan S, Aghoram R

ImmunoTargets and Therapy 2020, 9:79-93

Published Date: 14 May 2020

Immunotherapy for Medulloblastoma: Current Perspectives

Kabir TF, Kunos CA, Villano JL, Chauhan A

ImmunoTargets and Therapy 2020, 9:57-77

Published Date: 20 April 2020

Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis

Elemam NM, Hannawi S, Maghazachi AA

ImmunoTargets and Therapy 2020, 9:43-56

Published Date: 9 March 2020

Novel Resolution Mediators of Severe Systemic Inflammation

Gudernatsch V, Stefańczyk SA, Mirakaj V

ImmunoTargets and Therapy 2020, 9:31-41

Published Date: 6 March 2020

Immunoinformatics and Vaccine Development: An Overview

Oli AN, Obialor WO, Ifeanyichukwu MO, Odimegwu DC, Okoyeh JN, Emechebe GO, Adejumo SA, Ibeanu GC

ImmunoTargets and Therapy 2020, 9:13-30

Published Date: 26 February 2020

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update

Guallar-Garrido S, Julián E

ImmunoTargets and Therapy 2020, 9:1-11

Published Date: 13 February 2020